Pephexia Therapeutics
PrivateLast Round
Grant
Jul 1, 2024
Total Funding Raised
$7.16M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Pephexia Therapeutics operates in Healthcare & Life Sciences and is based in Frederiksberg. Its latest recorded funding round was a Grant round in July 2024.
Pephexia Therapeutics is a biotechnology company that focuses on the discovery and development of innovative peptide-based therapeutics for the treatment of cachexia, sarcopenia, and related metabolic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pephexia Therapeutics Comparables
Compare Pephexia Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Actimed Therapeutics | 80% | |
| Kalohexis | 78% | |
| Endevica Bio | 77% |
For institutional investors. Book with your work email.
Pephexia Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 1, 2024 | ||||
| Grant | Feb 7, 2024 | ||||
| Grant | Dec 1, 2023 | ||||
| Grant | Mar 9, 2022 | ||||
| VC Round | Dec 1, 2021 | ||||
Accelerator | Sep 23, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Pephexia Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovation Fund Denmark | Grant |
| Eurostars SME programme | Grant |
| The Export and Investment Fund of Denmark | VC Round |
| BioInnovation Institute | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 560% MoM, from 341 to 2.3K.
- Dec 9, 2025
Monthly visitors increased 84% MoM, reaching 1.3K.
For institutional investors. Book with your work email.
Pephexia Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Pephexia Therapeutics's valuation, stock price, and market status.
Is Pephexia Therapeutics a public or private company?
Pephexia Therapeutics is a private company.
What is the current stock price of Pephexia Therapeutics?
Pephexia Therapeutics is a private company, so its shares have no public market price. Caplight tracks Pephexia Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Pephexia Therapeutics worth (valuation)?
Valuation information for Pephexia Therapeutics is not publicly available.
Can I buy Pephexia Therapeutics stock?
Pephexia Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Pephexia Therapeutics's last funding round?
Pephexia Therapeutics's most recent funding round was Grant on July 1, 2024.
Who are the main investors in Pephexia Therapeutics?
Key investors in Pephexia Therapeutics include Innovation Fund Denmark, Eurostars SME programme, The Export and Investment Fund of Denmark, BioInnovation Institute.
Will Pephexia Therapeutics IPO soon?
No public IPO plans have been announced for Pephexia Therapeutics.
How can I track Pephexia Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Pephexia Therapeutics's shares on secondary markets.